Innovative Eyewear Inc. (LUCY) - Net Assets
Based on the latest financial reports, Innovative Eyewear Inc. (LUCY) has net assets worth $10.25 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($11.18 Million) and total liabilities ($925.00K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check LUCY financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $10.25 Million |
| % of Total Assets | 91.72% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 843.15 |
Innovative Eyewear Inc. - Net Assets Trend (2019–2024)
This chart illustrates how Innovative Eyewear Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore Innovative Eyewear Inc. assets under control for the complete picture of this company's asset base.
Annual Net Assets for Innovative Eyewear Inc. (2019–2024)
The table below shows the annual net assets of Innovative Eyewear Inc. from 2019 to 2024. For live valuation and market cap data, see LUCY stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $9.10 Million | +63.62% |
| 2023-12-31 | $5.56 Million | +38.13% |
| 2022-12-31 | $4.02 Million | +1839.33% |
| 2021-12-31 | $207.52K | +138.85% |
| 2020-12-31 | $-534.19K | -10.41% |
| 2019-12-31 | $-483.82K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Innovative Eyewear Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 2412446600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $25.00 | 0.00% |
| Other Components | $33.83 Million | 371.97% |
| Total Equity | $9.10 Million | 100.00% |
Innovative Eyewear Inc. Competitors by Market Cap
The table below lists competitors of Innovative Eyewear Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Emico Holdings Bhd
KLSE:9091
|
$5.52 Million |
|
Bumi Citra Permai Tbk
JK:BCIP
|
$5.53 Million |
|
Elecster Oyj A
HE:ELEAV
|
$5.53 Million |
|
North Atlantic Smaller Companies Investment Trust PLC
LSE:NAS
|
$5.53 Million |
|
Oriental Trimex Limited
NSE:ORIENTALTL
|
$5.52 Million |
|
Digistar Corporation Bhd
KLSE:0029
|
$5.51 Million |
|
Computer Forms (Malaysia) Bhd
KLSE:8044
|
$5.51 Million |
|
Saehwa IMC Co Ltd
KO:145210
|
$5.51 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Innovative Eyewear Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 5,558,826 to 9,095,141, a change of 3,536,315 (63.6%).
- Net loss of 7,766,515 reduced equity.
- New share issuances of 6,594,485 increased equity.
- Other factors increased equity by 4,708,345.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-7.77 Million | -85.39% |
| Share Issuances | $6.59 Million | +72.51% |
| Other Changes | $4.71 Million | +51.77% |
| Total Change | $- | 63.62% |
Book Value vs Market Value Analysis
This analysis compares Innovative Eyewear Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.17x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-4.87 | $1.03 | x |
| 2020-12-31 | $-3.61 | $1.03 | x |
| 2021-12-31 | $0.79 | $1.03 | x |
| 2022-12-31 | $12.33 | $1.03 | x |
| 2023-12-31 | $10.57 | $1.03 | x |
| 2024-12-31 | $6.08 | $1.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Innovative Eyewear Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -85.39%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -474.60%
- • Asset Turnover: 0.17x
- • Equity Multiplier: 1.08x
- Recent ROE (-85.39%) is above the historical average (-318.32%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -2269.80% | 0.00x | 0.00x | $-61.04K |
| 2020 | 0.00% | -1347.76% | 0.25x | 0.00x | $-714.76K |
| 2021 | -1563.50% | -469.76% | 0.84x | 3.97x | $-3.27 Million |
| 2022 | -141.18% | -861.16% | 0.14x | 1.17x | $-6.08 Million |
| 2023 | -119.87% | -578.18% | 0.19x | 1.12x | $-7.22 Million |
| 2024 | -85.39% | -474.60% | 0.17x | 1.08x | $-8.68 Million |
Industry Comparison
This section compares Innovative Eyewear Inc.'s net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,863,507,886
- Average return on equity (ROE) among peers: -17.76%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Innovative Eyewear Inc. (LUCY) | $10.25 Million | 0.00% | 0.09x | $5.52 Million |
| Akoya Biosciences Inc (AKYA) | $121.35 Million | -35.38% | 0.57x | $64.44 Million |
| Align Technology Inc (ALGN) | $1.35 Billion | 32.89% | 0.86x | $12.66 Billion |
| AngioDynamics Inc (ANGO) | $517.03 Million | -1.36% | 0.37x | $444.32 Million |
| AptarGroup Inc (ATR) | $2.71 Billion | 14.48% | 0.94x | $7.66 Billion |
| AtriCure Inc (ATRC) | $16.74 Million | -22.66% | 1.01x | $1.44 Billion |
| Avinger Inc (AVGR) | $-73.64 Million | 0.00% | 0.00x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $10.52 Million | -163.15% | 1.04x | $156.14 Million |
| Avantor Inc (AVTR) | $5.57 Billion | -9.53% | 1.12x | $5.43 Billion |
| Azenta Inc (AZTA) | $553.69 Million | -12.55% | 0.24x | $1.04 Billion |
| Baxter International Inc (BAX) | $7.87 Billion | 19.65% | 1.00x | $8.85 Billion |
About Innovative Eyewear Inc.
Lucyd, Inc engages in the development and sale of smart eyeglasses and sunglasses in North America. Its flagship product is the Lucyd Lyte which enable the wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform various smartphone tasks hands-free. It also provides Nautica Powered by Lucyd smart eyewear collection and various branded accessories, including … Read more